ArticleCancer2025
The American Cancer Society National Lung Cancer Roundtable strategic plan: Changing the lung cancer story: Addressing survivorship, stigma, and nihilism to facilitate transformation.
Article in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Lung Cancer Survivorship: Challenges and Care Needs.Cancers · 2026Review
- Psychosocial Determinants Among Hospital and Primary Healthcare Professionals Towards Cancer and Cancer Patients in Croatia.Journal of clinical medicine · 2026Article
- Confronting nihilism and stigma in lung cancer: The nurse practitioner's role in restoring hope and trust.Journal of the American Association of Nurse Practitioners · 2026Article
- Clinical trials in small-cell lung cancer treatment: a cross-sectional analysis of trial discontinuation and non-publication.Discover oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Innovations across the lung cancer continuum, from risk reduction through end-of-life care, have transformed the lung cancer landscape, and are dramatically altering the trajectory of lung cancer outcomes. Although the lung cancer community has been infused with optimism and hope regarding these positive developments, persistent societal perspectives regarding lung cancer and the complex relationship with smoking have been substantially slower to change. These barriers constrain the implementation of innovative and effective care, and hinder progress toward reducing lung cancer incidence and mortality. To address the prevailing societal barriers, the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) launched the Survivorship, Stigma, and Nihilism Task Group (SSNTG) soon after the inaugural 2017 ACS NLCRT meeting. Engaging a diverse group of individuals and organizations with expertise in these cardinal domains, the SSNTG, which consisted of clinicians, advocates, and researchers representing different disciplines and experiences, convened to develop a strategic plan to improve lung cancer survivorship and eliminate lung cancer stigma and nihilism as essential components of achieving optimal lung cancer outcomes. The SSNTG established a trilateral mission and launched the Campaign to End Lung Cancer Stigma and other efforts to support lung cancer survivorship and address lung cancer-related nihilism and fatalism. This commentary highlights the multilayered work of the SSNTG, including (1) background justification for each of the three targeted areas, (2) active initiatives to reduce lung cancer stigma and nihilism and improve lung cancer survivorship, and (3) next steps that the task group plans to pursue to support the ACS NLCRT mission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.